Published 10/02/2023 5:00:00 p.m.

New malaria vaccine approved by World Health Organization

The World Health Organization has recommended the use of a cheap malaria vaccine developed by the University of Oxford, which is the second malaria vaccine to be developed.
The R21 vaccine is 75% effective at preventing malaria in seasonal areas and is easier to manufacture and distribute than the previous vaccine.
The rollout of both the R21 and RTS,S vaccines is expected next year, providing a vital additional tool in the fight against malaria.

Insights by Ground AI

Does this summary seem wrong?

0 Articles

All

Left

Center

Right

Times of India

WHO recommends second malaria vaccine for children

The World Health Organization (WHO) has recommended an additional malaria vaccine for children, which could help save hundreds of thousands of lives. The new R21/Matrix-M vaccine, developed by Oxford University and manufactured by the Serum Institute of India, has already been approved for use in three African countries.

10/02/2023 2:49:52 p.m.·India

Read Full Article

BBC News

Malaria vaccine big advance against major child killer

Deals are in place to make 100 million doses of the vaccine each year to fight the complex disease.

10/02/2023 2:40:58 p.m.·United Kingdom

Read Full Article

News18 India

UN Authorises Second Malaria Vaccine; Experts Warn It's Not Enough to Stop the Disease Spreading

“As a malaria researcher, I used to dream of the day we would have a safe and effective vaccine against malaria. Now we have two,” Tedros said

10/02/2023 4:21:28 p.m.·India

Read Full Article

The Hindu

Oxford-Serum institute malaria vaccine recommended for use by WHO

WHO recommends R21/Matrix-M malaria vaccine developed by Oxford and Serum Institute of India. Vaccine has met safety, quality and effectiveness standards. Serum Institute has established production capacity for 100 million doses/annum. Vaccine efficacy over 12 months is 75% at sites with high seasonal malaria transmission and 68% at sites with more perennial transmission. Booster dose restores efficacy at seasonal sites with 74% efficacy over 18…

10/02/2023 5:36:17 p.m.·India

Read Full Article

The Independent

Major step in fight against malaria as Oxford-developed vaccine approved by WHO

It is estimated that around 500,000 children die of malaria each year

10/02/2023 6:29:43 p.m.·London, United Kingdom

Read Full Article

CBC News

WHO backs new malaria vaccine that's cheaper, more available, but won't replace other measures

Research suggests the new three-dose vaccine, called R21/Matrix-M, is more than 75 per cent effective and protection is maintained for at least another year with a booster. It's cheaper and more available than the current vaccine, but won't replace other measures, experts say.

10/02/2023 5:01:40 p.m.·Canada

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year